IL23诱导IL23R再循环并放大人类巨噬细胞中先天受体诱导的信号与细胞因子,且IBD保护性IL23R R381Q变异调节这些结果
该研究分析人单核细胞来源巨噬细胞(MDM)中IL23R的蛋白与RNA表达、信号传导及定位。IL23R对模式识别受体(PRR)诱导的信号与细胞因子达最佳水平至关重要,IL23诱导IL23R动态细胞表面调节,依赖网格蛋白和动力蛋白介导的内吞及内吞再循环途径。IBD保护性IL23R R381Q变异显示不同结果:表达IL23R Q381的HeLa细胞较IL23R R381再循环减少、与Janus激酶/信号转导及转录激活因子通路成员组装减少;IL23R Q381携带者MDM中IL23R在晚期内体和溶酶体积累,IL23R和PRR诱导的信号与细胞因子较IL23R R381 MDM减少。
要点
- IL23R对人类巨噬细胞中PRR诱导的信号与细胞因子达最佳水平至关重要。
- IL23诱导IL23R动态细胞表面调节,依赖网格蛋白和动力蛋白介导的内吞及再循环。
- IBD保护性IL23R R381Q变异减少IL23R再循环及IL23R/PRR诱导的信号与细胞因子。
核心结论
- 巨噬细胞介导的炎症通路是IBD发病的关键因素,研究确定PRR启动的人巨噬细胞及人肠道髓系细胞结果需要自分泌/旁分泌IL23。
- 研究确立IL23R经历配体诱导的再循环,定义调节IL23R诱导信号的机制,并确定IBD保护性IL23R R381Q变异如何调节这些过程。
研究设计与样本
- 通过western blot、ELISA、实时PCR、流式细胞术、免疫沉淀和显微镜分析人单核细胞来源巨噬细胞(MDM)的蛋白和RNA表达、信号及定位。
主要发现
- IL23R对人类MDM中PRR诱导的信号与细胞因子达最佳水平至关重要。
- 与核心受体IL12Rβ1不同,IL23诱导动态IL23R细胞表面调节,需要网格蛋白和动力蛋白介导的内吞及内吞再循环依赖途径,这些途径对IL23R介导的结果至关重要。
- 相对IL23R R381,表达IL23R Q381的HeLa细胞显示IL23R再循环减少及IL23R Q381与Janus激酶/信号转导及转录激活因子通路成员组装减少。
- IL23R Q381携带者MDM中,IL23处理时IL23R在晚期内体和溶酶体积累,细胞显示IL23R和PRR诱导的信号与细胞因子较IL23R R381 MDM减少。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: The interleukin (IL)23 pathway contributes to IBD pathogenesis and is being actively studied as a therapeutic target in patients with IBD. Unexpected outcomes in these therapeutic trials have highlighted the importance of understanding the cell types and mechanisms through which IL23 regulates immune outcomes. How IL23 regulates macrophage outcomes and the consequences of the IL23R R381Q IBD-protective variant on macrophages are not well defined; macrophages are key players in IBD pathogenesis and inflammation. DESIGN: We analysed protein and RNA expression, signalling and localisation in human monocyte-derived macrophages (MDMs) through western blot, ELISA, real-time PCR, flow cytometry, immunoprecipitation and microscopy. RESULTS: IL23R was critical for optimal levels of pattern-recognition receptor (PRR)-induced signalling and cytokines in human MDMs. In contrast to the coreceptor IL12Rβ1, IL23 induced dynamic IL23R cell surface regulation and this required clathrin and dynamin-mediated endocytosis and endocytic recycling-dependent pathways; these pathways were essential for IL23R-mediated outcomes. The IBD-protective IL23R R381Q variant showed distinct outcomes. Relative to IL23R R381, HeLa cells expressing IL23R Q381 showed decreased IL23R recycling and reduced assembly of IL23R Q381 with Janus kinase/signal transducer and activator of transcription pathway members. In MDMs from IL23R Q381 carriers, IL23R accumulated in late endosomes and lysosomes on IL23 treatment and cells demonstrated decreased IL23R- and PRR-induced signalling and cytokines relative to IL23R R381 MDMs. CONCLUSION: Macrophage-mediated inflammatory pathways are key contributors to IBD pathogenesis, and we identify an autocrine/paracrine IL23 requirement in PRR-initiated human macrophage outcomes and in human intestinal myeloid cells, establish that IL23R undergoes ligand-induced recycling, define mechanisms regulating IL23R-induced signalling and determine how the IBD-protective IL23R R381Q variant modulates these processes.
引用
- Sun R, Hedl M, Abraham C, et al. IL23 induces IL23R recycling and amplifies innate receptor-induced signalling and cytokines in human macrophages, and the IBD-protective IL23R R381Q variant modulates these outcomes. Gut. 2019. PMID: 31097538. doi:10.1136/gutjnl-2018-316830
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。